Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02766: Variant p.Phe84Leu

Transthyretin
Gene: TTR
Feedback?
Variant information Variant position: help 84 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Phenylalanine (F) to Leucine (L) at position 84 (F84L, p.Phe84Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (F) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AMYLD1; amyloid polyneuropathy. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 84 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 147 The length of the canonical sequence.
Location on the sequence: help FASGKTSESGELHGLTTEEE F VEGIYKVEIDTKSYWKALGI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         FASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGI

Chimpanzee                    FASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGI

Mouse                         FASGKTAESGELHGLTTDEKFVEGVYRVELDTKSYWKTLGI

Rat                           FASGKTAESGELHGLTTDEKFTEGVYRVELDTKSYWKALGI

Pig                           FALGKTSEFGELHGLTTDEKFVEGIYKVELDTKSYWKALGI

Bovine                        FASGKTSESGELHGLTTEDKFVEGLYKVELDTKSYWKSLGI

Rabbit                        FASGKTSKTGELHGLTTSEKFVEGVYKVELDTKSYWKALGI

Sheep                         FASGKTSDSGELHGLTTEDKFVEGLYKVELDTKSYWKSLGI

Chicken                       FATGKTTEFGEIHELTTEEQFVEGVYRVEFDTSSYWKGLGL

Xenopus laevis                ITSGKTTELGEIHNLTTDEQFTEGVYKIEFATKAFWGKLGL

Xenopus tropicalis            ISSGKTTELGEIHNIITDEQFTEGVYKIEFATKTFWRKLGL
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 21 – 147 Transthyretin
Binding site 74 – 74
Modified residue 72 – 72 Phosphoserine



Literature citations
Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals two novel point mutations.
Li S.; Minnerath S.; Li K.; Dyck P.J.; Sommer S.S.;
Neurology 41:893-898(1991)
Cited for: VARIANTS AMYLD1 LEU-53 AND LEU-84; Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.
Lim A.; Prokaeva T.; McComb M.E.; O'Connor P.B.; Theberge R.; Connors L.H.; Skinner M.; Costello C.E.;
Anal. Chem. 74:741-751(2002)
Cited for: VARIANTS SER-26 AND MET-139; VARIANTS AMYLD1 ALA-58; LEU-61; SER-64 AND LEU-84; IDENTIFICATION BY MASS SPECTROMETRY; Genetic microheterogeneity of human transthyretin detected by IEF.
Altland K.; Benson M.D.; Costello C.E.; Ferlini A.; Hazenberg B.P.C.; Hund E.; Kristen A.V.; Linke R.P.; Merlini G.; Salvi F.; Saraiva M.J.; Singer R.; Skinner M.; Winter P.;
Electrophoresis 28:2053-2064(2007)
Cited for: VARIANTS AMYLD1 PRO-32; ILE-40; SER-44; ALA-50; MET-50; LEU-53; VAL-53; PRO-56; THR-65; ALA-67; ALA-69; ILE-69; ALA-80; LEU-84; LEU-88; ALA-91; TYR-97; PHE-98; SER-104; ASN-104; THR-104; ALA-114; GLY-117; ASN-126; MET-127; VAL-127; MET-131 AND ILE-142; VARIANTS ILE-33; SER-121 AND THR-129; VARIANT CHICAGO MET-139;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.